Dogwood Therapeutics(DWTX)

ALPHARETTA, GA

Biotechnology

Focus: Small Molecules

Dogwood Therapeutics is a life sciences company focused on Small Molecules.

Neurology

Funding Stage

PUBLIC

Employees

501-1000

Open Jobs

Pipeline & Clinical Trials

Halneuron

Phase 2

Clinical Trials (1)

NCT06848348Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Phase 2

No open positions listed yet.

Interview Prep Quick Facts

Portfolio: 1 clinical trial

SEC Filings: 2 available

R&D Spend

$2M79%

Net Income

-$5M

Cash

$3M